PAS
CTKB icon

Point72 Asia (Singapore)’s Cytek Biosciences CTKB Stock Holding History

Point72 Asia (Singapore)’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$38.9K Sell
11,198
-20,397
-65% -$76.6K 0.01% 606
2025
Q2 		$107K Buy
31,595
+15,824
+100% +$52.7K 0.02% 460
2025
Q1 		$63.2K Buy
15,771
+4,407
+39% +$22.8K 0.02% 519
2024
Q4 		$73.8K Buy
+11,364
New +$67.7K 0.02% 430

Other funds holding CTKB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Asia (Singapore)'s CTKB Position: Q3 2025 in Review

Point72 Asia (Singapore) reduced its Cytek Biosciences (CTKB) stake by 65% in Q3 2025, selling an estimated $76.6K and leaving 11,198 shares worth $38.9K. The position accounts for 0.01% of the portfolio, ranked #606.

Point72 Asia (Singapore) first reported a position in CTKB in Q4 2024 and has held it in 4 quarters since. The position peaked at $107K in Q2 2025. 153 funds tracked by Wall St. Rank hold CTKB as of Q3 2025.

  • Point72 Asia (Singapore) held 11,198 shares of Cytek Biosciences worth $38.9K as of Q3 2025.
  • Point72 Asia (Singapore) sold 20,397 Cytek Biosciences shares in Q3 2025, an estimated $76.6K.
  • Cytek Biosciences made up 0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #606 holding.
  • Point72 Asia (Singapore) first reported a position in Cytek Biosciences in Q4 2024 and has held it in 4 quarters since.
  • Point72 Asia (Singapore)'s Cytek Biosciences position peaked at $107K in Q2 2025.
  • 153 funds tracked by Wall St. Rank held Cytek Biosciences as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.